Maximum quantity allowed is 999
Please select the quantity
CAS RN: 144875-48-9 | Product Number: R0197
Resiquimod
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 25MG |
$120.00
|
1 | 4 | It can be shipped in about 2 weeks after ordering | |
| 100MG |
$352.00
|
16 | 27 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| Product Number | R0197 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__7H__2__2N__4O__2 = 314.39 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic,Heat Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 25MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 144875-48-9 |
| Reaxys Registry Number | 9792901 |
| PubChem Substance ID | 354335079 |
| Merck Index (14) | 8151 |
| MDL Number | MFCD00937759 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
Properties (reference)
| Melting Point | 193 °C |
| Maximum Absorption Wavelength | 325 nm |
GHS
Related Laws:
| RTECS# | NJ5911320 |
Transport Information:
| H.S.code* | 2933.99-000 |
Application
Resiquimod: A Toll-Like Receptor Agonist
Resiquimod (R-848) is a tricyclic imidazoquinolone compound and an imiquimod [I0747] analog. Toll-like receptors (TLRs) play an important role in the innate immune response to pathogens. Reportedly, resiquimod act as an immunomodulator and an anti-viral agent through activation immune cells via the Toll-like receptor 7 and 7/8 (TLR7 and TLR7/8) dependent signaling pathway. And then, resiquimod induces mRNA encoding cytokines including interferon-α (INF-α) at the treatment site. (The product is for research purpose only.)
References
- Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
- The antiviral activity of toll-like receptor 7 and 7/8 agonists (a review)
- The use of Toll-like receptor 7/8 agonists as vaccine adjuvants (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.